Aqua Bio Technology - Board/Management Information 2025

Aqua Bio Technology ASA - CEO and CFO

30.6.2025 08:00:00 CEST | Aqua Bio Technology ASA | Additional regulated

information required to be disclosed under the laws of a member state

Aqua Bio Technology ASA has appointed Kristian Flaten as Chief Executive

Officer, effective from 1 August 2025.

During an interim period, Kristian will also hold the position as Chief

Financial Officer.

Kristian Flaten brings over 25 years of financial and business leadership, with

proven track record in management, finance, corporate governance and business

development from listed growth companies and international organisations.

Kristian has a background as CFO with IDEX Biometrics ASA and Quantafuel ASA,

with additional experience from BW Offshore, Eksportkreditt (Eksfin) and

Handelsbanken.

Kristian holds a Master of Science from NHH (Norwegian School of Economics),

with majors in Finance and Strategy.

The board of Aqua Bio Technology has previously announced that the company will

enter a phase with new priorities and cost adjustments. The board will conclude

on these topics during the second half of 2025.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Roger Sedal, Chair of the Board of Directors, Aqua Bio Technology ASA,

* Terje Blytt, JetCarrier AS, +4769184030

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology ASA (ABTEC) is a distribution group i skincare and non-food.

The group has distribution towards B2C, B2B, B2B2, and freight, customs, and

logistics services. The group also develops sustainable biotechnology for use in

skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo. market

of the Oslo Stock Exchange.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/18584231/6260/Download%20announce

ment%20as%20PDF.pdf

AI assistant